JP2008545782A - 5−(4−メチル−1h−イミダゾール−1−イル)−3−(トリフルオロメチル)−ベンゼンアミンの合成法 - Google Patents
5−(4−メチル−1h−イミダゾール−1−イル)−3−(トリフルオロメチル)−ベンゼンアミンの合成法 Download PDFInfo
- Publication number
- JP2008545782A JP2008545782A JP2008515848A JP2008515848A JP2008545782A JP 2008545782 A JP2008545782 A JP 2008545782A JP 2008515848 A JP2008515848 A JP 2008515848A JP 2008515848 A JP2008515848 A JP 2008515848A JP 2008545782 A JP2008545782 A JP 2008545782A
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- trifluoromethyl
- imidazole
- compound
- process according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WWTGXYAJVXKEKL-UHFFFAOYSA-N 3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)aniline Chemical compound C1=NC(C)=CN1C1=CC(N)=CC(C(F)(F)F)=C1 WWTGXYAJVXKEKL-UHFFFAOYSA-N 0.000 title claims abstract description 5
- 238000001308 synthesis method Methods 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 17
- 150000001875 compounds Chemical class 0.000 claims description 26
- XLSZMDLNRCVEIJ-UHFFFAOYSA-N 4-methylimidazole Chemical compound CC1=CNC=N1 XLSZMDLNRCVEIJ-UHFFFAOYSA-N 0.000 claims description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 11
- 239000003054 catalyst Substances 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- JMLCVCGQBRZYOZ-UHFFFAOYSA-N 4-methyl-1-[3-nitro-5-(trifluoromethyl)phenyl]imidazole Chemical compound C1=NC(C)=CN1C1=CC([N+]([O-])=O)=CC(C(F)(F)F)=C1 JMLCVCGQBRZYOZ-UHFFFAOYSA-N 0.000 claims description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 8
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 8
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical group [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- 238000005859 coupling reaction Methods 0.000 claims description 4
- 229910052763 palladium Inorganic materials 0.000 claims description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 4
- 229910000564 Raney nickel Inorganic materials 0.000 claims description 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 239000007868 Raney catalyst Substances 0.000 claims description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 claims description 2
- 150000004703 alkoxides Chemical class 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 claims description 2
- 150000004678 hydrides Chemical class 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims description 2
- 229910052697 platinum Inorganic materials 0.000 claims description 2
- 239000003880 polar aprotic solvent Substances 0.000 claims description 2
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 claims 1
- 238000006722 reduction reaction Methods 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 5
- JGJYPPNLUXMOKO-UHFFFAOYSA-N 2-(pyrimidin-2-ylamino)benzamide Chemical class NC(=O)C1=CC=CC=C1NC1=NC=CC=N1 JGJYPPNLUXMOKO-UHFFFAOYSA-N 0.000 abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 238000005984 hydrogenation reaction Methods 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- YEAOVYLCHBNHNT-UHFFFAOYSA-N 1,2-dinitro-3-(trifluoromethyl)benzene Chemical compound [O-][N+](=O)C1=CC=CC(C(F)(F)F)=C1[N+]([O-])=O YEAOVYLCHBNHNT-UHFFFAOYSA-N 0.000 description 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- -1 potassium alkoxide Chemical class 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- LXBGSDVWAMZHDD-UHFFFAOYSA-N 2-methyl-1h-imidazole Chemical compound CC1=NC=CN1 LXBGSDVWAMZHDD-UHFFFAOYSA-N 0.000 description 1
- YZEUHQHUFTYLPH-UHFFFAOYSA-N 2-nitroimidazole Chemical compound [O-][N+](=O)C1=NC=CN1 YZEUHQHUFTYLPH-UHFFFAOYSA-N 0.000 description 1
- WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- HWIMSVNMNRKYOY-QPYLURDPSA-N C/C=C/N(/C=N\C)c1cc(C#N)cc(C)c1 Chemical compound C/C=C/N(/C=N\C)c1cc(C#N)cc(C)c1 HWIMSVNMNRKYOY-QPYLURDPSA-N 0.000 description 1
- GXXTYCKSVROUIT-UHFFFAOYSA-N CCc(nc1)c[n]1-c1cc(N)cc(C(F)(F)F)c1 Chemical compound CCc(nc1)c[n]1-c1cc(N)cc(C(F)(F)F)c1 GXXTYCKSVROUIT-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 238000006969 Curtius rearrangement reaction Methods 0.000 description 1
- 101100335081 Mus musculus Flt3 gene Proteins 0.000 description 1
- AYNUKEDZAYOEGG-UHFFFAOYSA-N N#Cc1cc(C(F)(F)F)cc(F)c1 Chemical compound N#Cc1cc(C(F)(F)F)cc(F)c1 AYNUKEDZAYOEGG-UHFFFAOYSA-N 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 108091008606 PDGF receptors Proteins 0.000 description 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 1
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000007080 aromatic substitution reaction Methods 0.000 description 1
- 229940045348 brown mixture Drugs 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- ASMQGLCHMVWBQR-UHFFFAOYSA-M diphenyl phosphate Chemical compound C=1C=CC=CC=1OP(=O)([O-])OC1=CC=CC=C1 ASMQGLCHMVWBQR-UHFFFAOYSA-M 0.000 description 1
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- HHZIURLSWUIHRB-UHFFFAOYSA-N nilotinib Chemical compound C1=NC(C)=CN1C1=CC(NC(=O)C=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)=CC(C(F)(F)F)=C1 HHZIURLSWUIHRB-UHFFFAOYSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000007339 nucleophilic aromatic substitution reaction Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
スキーム1
本発明の一般的な反応スキームは下記の態様を説明において説明され得る:
200L容器中に、9kgのジニトロベンゾトリフルオリド、5.3kgの炭酸カリウムおよび84.6kgのDMAを入れる。良く混合されるまで撹拌し(暗赤色)、10分後、3.8kgの4−メチル−1H−イミダゾールを加え、混合物を撹拌下で95℃で15−20時間撹拌しながら、分析で出発物質がないことが示されるまで加熱する。暗赤−褐色混合物を30℃に冷却し、良く撹拌しながら水に注ぎ、濾過し、水で洗浄し、約5kgの粗生成物を暗褐色の湿った固体として得る。分析は1:9の不適切な異性体を示す。この固体を加熱下でシクロヘキサンおよび炭で処理し、次いで混合物を浄化し、ケーキを熱シクロヘキサンで洗浄する。合わせた濾液を室温に冷却し、ベージュ色の固体が沈殿する。予想収量:2.6−3.6kg;25−35%。
実施例1に従い製造した34.4gのニトロ中間体(III)、1.72g、5%のPd/Cおよび217mLのメタノールを水素化容器内に入れた。通常の不活性化後、水素化を70−75℃で4.2−7.5barで2時間実施した。ガスクロマトグラフィー分析による反応完了後、触媒を濾取し、次いでメタノールで濯いだ。濾液を合わせ、ほとんどの溶媒を真空下で留去した。174mLのメタノールおよび526mLのアセトンを固体残渣に加えた。17gの塩酸水溶液の添加後、塩酸塩が沈殿した。懸濁液を−10℃から−5℃に冷却し、30分間撹拌した。次いで、塩を濾過し、58mLのアセトンで洗浄した。319mLのメタノールを湿った塩酸塩に加え、懸濁液を58−62℃に加熱した。18gの重炭酸ナトリウムおよび756gの水を添加後、溶液を濾過し、3−7℃に冷却した。化合物(I)の結晶化生成物を濾過し、水で洗浄し、真空下で60−75℃で乾燥させた(収量:19.1g、理論値の62%、純度>99%)。
下記はラネーニッケル触媒を使用する水素化方法を含む。ニトロ中間体(III)(7.5kg)、ラネーニッケル(0.375kg)およびメタノール(32.5kg)を入れる;そして窒素パージおよび減圧を数回および次いで水素パージ+減圧を3回行う。圧力を4barに調節し、次いで70℃に加熱する。圧力を水素が消費されるまで4barで維持する;次いで、この温度でさらに2時間撹拌する。圧力およびサンプルは底弁により放出される。分析によって反応が完了しないとき、70℃に4barHガス下でもう1時間撹拌しながら再加熱する。反応が完了したとき、反応混合物をカートリッジフィルターを介して浄化する。溶媒を真空蒸留により除去し(最高60℃)、残渣にトルエン(44kg)およびアセトン(121kg)を加える。この混合物に、塩酸(3.7kg)を滴下する。白色固体を遠心し、アセトンで洗浄する。この固体をメタノール(55kg)中に60℃で溶解し、この溶液にもう1回の水(165kg)中の重炭酸ナトリウム(3.95kg)を60℃以下の温度を維持しながら加える。0.7kgの炭素を加え、混合物を60℃で1時間撹拌する。次いで浄化し、15−20℃に冷却する。1時間この温度で撹拌後、混合物を遠心し、2回水で洗浄する。固体を水含有率が0.5%以下になるまで乾燥させる。期待される量は5.5kg(82.5%の収率)である。
Claims (10)
- 工程a)が80−150℃の範囲の温度で実施される請求項1に記載の方法。
- 工程a)が90−140℃の範囲の温度で実施される請求項1に記載の方法。
- 還元反応工程b)がVIII属の金属触媒、水素ガスまたは水素移動剤を含む請求項1に記載の方法。
- 触媒がパラジウム、白金またはラネーニッケルまたはそれらの組合せである請求項4に記載の方法。
- 塩基がアルコキシド、水素化物、炭酸またはリン酸である請求項6に記載の方法。
- 工程a)でジメチルスルホキシド(DMSO)、ジメチルホルムアミド(DMF)、ジグライム、THF、N−メチルピロリドン(NMP)およびジメチルアセトアミド(DMA)から選択される極性非プロトン溶媒を使用する請求項1または6に記載の方法。
- マイクロウェーブが使用される請求項1に記載の方法。
- 高い選択性を得るために速い加熱および冷却サイクルをバッチ容器における付加的な熱交換機能力によりまたは連続反応装置を使用することにより達成する、請求項1に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68892005P | 2005-06-09 | 2005-06-09 | |
US60/688,920 | 2005-06-09 | ||
PCT/US2006/022026 WO2006135619A1 (en) | 2005-06-09 | 2006-06-07 | Process for the synthesis of 5- (methyl- 1h-imidazol-1-yl) -3- (trifluoromethyl) -benzeneamine |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2008545782A true JP2008545782A (ja) | 2008-12-18 |
JP2008545782A5 JP2008545782A5 (ja) | 2009-07-23 |
JP5139273B2 JP5139273B2 (ja) | 2013-02-06 |
Family
ID=37085334
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008515848A Expired - Fee Related JP5139273B2 (ja) | 2005-06-09 | 2006-06-07 | 5−(4−メチル−1h−イミダゾール−1−イル)−3−(トリフルオロメチル)−ベンゼンアミンの合成法 |
Country Status (20)
Country | Link |
---|---|
US (1) | US7709657B2 (ja) |
EP (1) | EP1896425B1 (ja) |
JP (1) | JP5139273B2 (ja) |
KR (1) | KR101319071B1 (ja) |
CN (1) | CN101193866B (ja) |
AR (1) | AR057351A1 (ja) |
AT (1) | ATE483690T1 (ja) |
AU (1) | AU2006258116B2 (ja) |
BR (1) | BRPI0611924A2 (ja) |
CA (1) | CA2610402C (ja) |
DE (1) | DE602006017369D1 (ja) |
ES (1) | ES2354115T3 (ja) |
GT (1) | GT200600207A (ja) |
MX (1) | MX2007015420A (ja) |
PE (1) | PE20070084A1 (ja) |
PL (1) | PL1896425T3 (ja) |
PT (1) | PT1896425E (ja) |
RU (1) | RU2404167C2 (ja) |
TW (1) | TW200710084A (ja) |
WO (1) | WO2006135619A1 (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY146795A (en) * | 2005-06-09 | 2012-09-28 | Novartis Ag | Process for the synthesis of organic compounds |
GB0618832D0 (en) * | 2006-09-25 | 2006-11-01 | Phoenix Chemicals Ltd | Chemical process |
US20110053968A1 (en) | 2009-06-09 | 2011-03-03 | Auspex Pharmaceuticals, Inc. | Aminopyrimidine inhibitors of tyrosine kinase |
US10005439B2 (en) | 2014-05-16 | 2018-06-26 | Robert Bosch Gmbh | ABS hydraulic unit |
KR102335216B1 (ko) | 2017-04-26 | 2021-12-03 | 삼성전자 주식회사 | 발광소자 패키지 |
CN107235910B (zh) * | 2017-07-31 | 2020-04-24 | 安礼特(上海)医药科技有限公司 | 一种尼洛胺的合成方法 |
CN108530364B (zh) | 2018-04-10 | 2020-01-21 | 江苏创诺制药有限公司 | 一种3-(4-甲基-1h-咪唑-1-基)-5-三氟甲基苯胺单盐酸盐的晶型及其应用 |
CN115192540A (zh) | 2018-06-15 | 2022-10-18 | 汉达癌症医药责任有限公司 | 激酶抑制剂的盐类及其组合物 |
JP7181729B2 (ja) | 2018-08-23 | 2022-12-01 | 株式会社テイエルブイ | 気液分離器 |
EP3904342A1 (en) | 2020-04-28 | 2021-11-03 | Grindeks, A Joint Stock Company | Process for the preparation of 3-(trifluoromethyl)-5-(4-methyl-1h-imidazole-1-yl)-benzeneamine hydrochloride |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6182A (ja) * | 1984-05-29 | 1986-01-06 | フアイザー・コーポレーシヨン | キノロン変力剤 |
JP2003529558A (ja) * | 2000-01-21 | 2003-10-07 | アゴウロン・ファーマスーティカルス・インコーポレーテッド | プロテインキナーゼを阻害するためのアミド化合物 |
WO2003099771A2 (en) * | 2002-05-29 | 2003-12-04 | Novartis Ag | Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
WO2004005281A1 (en) * | 2002-07-05 | 2004-01-15 | Novartis Ag | Inhibitors of tyrosine kinases |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6323366B1 (en) | 1997-07-29 | 2001-11-27 | Massachusetts Institute Of Technology | Arylamine synthesis |
US6395916B1 (en) * | 1998-07-10 | 2002-05-28 | Massachusetts Institute Of Technology | Ligands for metals and improved metal-catalyzed processes based thereon |
US7202367B2 (en) * | 2002-05-31 | 2007-04-10 | Rhodia Chimie | Process for arylating or vinylating or alkynating a nucleophilic compound |
-
2006
- 2006-05-18 GT GT200600207A patent/GT200600207A/es unknown
- 2006-06-07 PE PE2006000629A patent/PE20070084A1/es not_active Application Discontinuation
- 2006-06-07 BR BRPI0611924-7A patent/BRPI0611924A2/pt active Search and Examination
- 2006-06-07 AU AU2006258116A patent/AU2006258116B2/en not_active Ceased
- 2006-06-07 ES ES06772366T patent/ES2354115T3/es active Active
- 2006-06-07 RU RU2007147927/04A patent/RU2404167C2/ru active
- 2006-06-07 EP EP06772366A patent/EP1896425B1/en active Active
- 2006-06-07 CA CA2610402A patent/CA2610402C/en active Active
- 2006-06-07 JP JP2008515848A patent/JP5139273B2/ja not_active Expired - Fee Related
- 2006-06-07 DE DE602006017369T patent/DE602006017369D1/de active Active
- 2006-06-07 US US11/915,658 patent/US7709657B2/en active Active
- 2006-06-07 PL PL06772366T patent/PL1896425T3/pl unknown
- 2006-06-07 WO PCT/US2006/022026 patent/WO2006135619A1/en active Application Filing
- 2006-06-07 AR ARP060102368A patent/AR057351A1/es not_active Application Discontinuation
- 2006-06-07 CN CN2006800202295A patent/CN101193866B/zh not_active Expired - Fee Related
- 2006-06-07 MX MX2007015420A patent/MX2007015420A/es active IP Right Grant
- 2006-06-07 PT PT06772366T patent/PT1896425E/pt unknown
- 2006-06-07 AT AT06772366T patent/ATE483690T1/de active
- 2006-06-07 KR KR1020077028640A patent/KR101319071B1/ko active IP Right Grant
- 2006-06-08 TW TW095120303A patent/TW200710084A/zh unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6182A (ja) * | 1984-05-29 | 1986-01-06 | フアイザー・コーポレーシヨン | キノロン変力剤 |
JP2003529558A (ja) * | 2000-01-21 | 2003-10-07 | アゴウロン・ファーマスーティカルス・インコーポレーテッド | プロテインキナーゼを阻害するためのアミド化合物 |
WO2003099771A2 (en) * | 2002-05-29 | 2003-12-04 | Novartis Ag | Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
WO2004005281A1 (en) * | 2002-07-05 | 2004-01-15 | Novartis Ag | Inhibitors of tyrosine kinases |
Also Published As
Publication number | Publication date |
---|---|
CN101193866A (zh) | 2008-06-04 |
RU2404167C2 (ru) | 2010-11-20 |
AU2006258116A1 (en) | 2006-12-21 |
PT1896425E (pt) | 2010-11-30 |
MX2007015420A (es) | 2008-02-21 |
PE20070084A1 (es) | 2007-03-09 |
JP5139273B2 (ja) | 2013-02-06 |
AU2006258116B2 (en) | 2010-11-25 |
CA2610402A1 (en) | 2006-12-21 |
RU2007147927A (ru) | 2009-07-20 |
ATE483690T1 (de) | 2010-10-15 |
US7709657B2 (en) | 2010-05-04 |
PL1896425T3 (pl) | 2011-04-29 |
TW200710084A (en) | 2007-03-16 |
ES2354115T3 (es) | 2011-03-10 |
EP1896425A1 (en) | 2008-03-12 |
KR101319071B1 (ko) | 2013-10-17 |
US20080200691A1 (en) | 2008-08-21 |
BRPI0611924A2 (pt) | 2010-10-05 |
GT200600207A (es) | 2007-01-15 |
CN101193866B (zh) | 2011-01-19 |
AR057351A1 (es) | 2007-11-28 |
DE602006017369D1 (de) | 2010-11-18 |
WO2006135619A1 (en) | 2006-12-21 |
EP1896425B1 (en) | 2010-10-06 |
CA2610402C (en) | 2014-09-16 |
KR20080016618A (ko) | 2008-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5139273B2 (ja) | 5−(4−メチル−1h−イミダゾール−1−イル)−3−(トリフルオロメチル)−ベンゼンアミンの合成法 | |
EP1896426B1 (en) | Process for the synthesis of organic compounds | |
EP0253396A2 (en) | Process for preparing 5,6-substituted-2,4-quinazolinediamines and intermediates | |
JP4028912B2 (ja) | 新規なシクロプロピルアニリン類及びその製造方法 | |
JPH0867673A (ja) | 5−イミダゾール−1−イル−2−ニトロアニリンの製造方法 | |
JPS63196587A (ja) | N−アルキルキノロンカルボン酸誘導体の製法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090603 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090603 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120522 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120821 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120828 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20121016 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20121115 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5139273 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20151122 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |